Habiccor Ointment contains Halobetasol 0.05% w/w, a potent topical corticosteroid indicated for the treatment of various inflammatory and pruritic dermatoses responsive to corticosteroid therapy. Halobetasol exerts anti-inflammatory, antipruritic, and vasoconstrictive effects by inhibiting multiple inflammatory cytokines and mediators involved in the pathogenesis of skin disorders. Habiccor Ointment is primarily used in conditions such as psoriasis, eczema, dermatitis, and lichen planus, providing rapid relief from symptoms including redness, swelling, itching, and discomfort. The ointment formulation facilitates enhanced skin penetration and prolonged contact time, optimizing therapeutic efficacy. It is recommended for short-term use due to the risk of adverse effects associated with potent corticosteroids, including skin atrophy, telangiectasia, and potential systemic absorption leading to hypothalamic-pituitary-adrenal (HPA) axis suppression. Application should be limited to affected areas, avoiding occlusive dressings unless directed by a healthcare professional. Contraindications include hypersensitivity to Halobetasol or any ointment components, untreated bacterial, viral, or fungal skin infections, and use in pediatric patients under supervision. Patients should adhere strictly to prescribed dosing regimens and report any signs of local irritation or systemic effects. Habiccor Ointment should be stored at room temperature, away from direct sunlight and moisture.